71 related articles for article (PubMed ID: 27605400)
1. Different profile of thrombin generation in children with acute lymphoblastic leukaemia treated with native or pegylated asparaginase: A cohort study.
Rozen L; Noubouossie D; Dedeken L; Huybrechts S; Lê PQ; Ferster A; Demulder A
Pediatr Blood Cancer; 2017 Feb; 64(2):294-301. PubMed ID: 27605400
[TBL] [Abstract][Full Text] [Related]
2. Outcomes and adverse events in older acute lymphoblastic Leukemia patients treated with a pediatric-inspired protocol with Pegylated or native Asparaginase.
Perusini MA; Andrews C; Atenafu EG; Gupta V; Maze D; Schuh AC; Yee KW; Bankar A; Davidson MB; Richard-Carpentier G; Chan SM; Sibai J; Schimmer AD; Minden MD; Sibai H
Hematology; 2024 Dec; 29(1):2329027. PubMed ID: 38526239
[TBL] [Abstract][Full Text] [Related]
3. Pegylated-asparaginase during induction therapy for adult acute lymphoblastic leukaemia: toxicity data from the UKALL14 trial.
Patel B; Kirkwood AA; Dey A; Marks DI; McMillan AK; Menne TF; Micklewright L; Patrick P; Purnell S; Rowntree CJ; Smith P; Fielding AK
Leukemia; 2017 Jan; 31(1):58-64. PubMed ID: 27480385
[TBL] [Abstract][Full Text] [Related]
4. Thrombin generation profile using ST-Genesia after PEG-asparaginase in pediatric patients with acute lymphoblastic leukemia.
Ruiz-Llobet A; Gassiot S; Sarrate E; Zubicaray J; Rives S; Suleman W; Berrueco R
Thromb Haemost; 2024 Apr; ():. PubMed ID: 38684189
[TBL] [Abstract][Full Text] [Related]
5. A Pilot Study of Intensified PEG-Asparaginase in High-risk Acute Lymphoblastic Leukemia: Children's Oncology Group Study AALL08P1.
Rodriguez V; Kairalla J; Salzer WL; Raetz EA; Loh ML; Carroll AJ; Heerema NA; Wood BL; Borowitz MJ; Burke MJ; Asselin BL; Devidas M; Winick NJ; Carroll WL; Hunger SP; Dreyer ZE
J Pediatr Hematol Oncol; 2016 Aug; 38(6):409-17. PubMed ID: 27299599
[TBL] [Abstract][Full Text] [Related]
6. Evaluation for inherited and acquired prothrombotic defects predisposing to symptomatic thromboembolism in children with acute lymphoblastic leukemia: a protocol for a prospective, observational, cohort study.
Athale UH; Laverdiere C; Nayiager T; Delva YL; Foster G; Thabane L; Chan AK
BMC Cancer; 2017 May; 17(1):313. PubMed ID: 28472942
[TBL] [Abstract][Full Text] [Related]
7. Antibodies Predict Pegaspargase Allergic Reactions and Failure of Rechallenge.
Liu Y; Smith CA; Panetta JC; Yang W; Thompson LE; Counts JP; Molinelli AR; Pei D; Kornegay NM; Crews KR; Swanson H; Cheng C; Karol SE; Evans WE; Inaba H; Pui CH; Jeha S; Relling MV
J Clin Oncol; 2019 Aug; 37(23):2051-2061. PubMed ID: 31188727
[TBL] [Abstract][Full Text] [Related]
8. [Prevention and management of pegaspargase associated-toxicities (excluding coagulation abnormalities). Recommendations of the French Society of Children and Adolescent Cancers (Leukemia committee)].
Poirée M; Neumann F; Thomas C; Simon P; Lunven AFR; Plantaz D; Doulet ST; Strullu M
Bull Cancer; 2022 Nov; 109(11):1125-1131. PubMed ID: 35987855
[TBL] [Abstract][Full Text] [Related]
9. The impact of early PEG-asparaginase discontinuation in young adults with ALL: a post hoc analysis of the CALGB 10403 study.
Aldoss I; Yin J; Wall A; Mrózek K; Liedtke M; Claxton DF; Foster MC; Appelbaum FR; Erba HP; Litzow MR; Tallman MS; Stone RM; Larson RA; Advani AS; Stock W; Luger SM
Blood Adv; 2023 Jan; 7(2):196-204. PubMed ID: 36269846
[TBL] [Abstract][Full Text] [Related]
10. Managing toxicities with asparaginase-based therapies in adult ALL: summary of an ESMO Open-Cancer Horizons roundtable discussion.
Burke PW; Hoelzer D; Park JH; Schmiegelow K; Douer D
ESMO Open; 2020 Oct; 5(5):e000858. PubMed ID: 33037033
[TBL] [Abstract][Full Text] [Related]
11. Hypoglycemia Associated With PEG-asparaginase and 6-MP Therapy During Treatment of Acute Lymphoblastic Leukemia in Pediatric Patients: A Case Series.
Jiang MR; Ahmet A; Lawrence S; Bassal M; Speckert M; Geraghty MT; Somerville S
J Pediatr Hematol Oncol; 2024 Mar; 46(2):e121-e126. PubMed ID: 38411659
[TBL] [Abstract][Full Text] [Related]
12. Successful treatment of acute lymphoblastic leukemia (ALL) during pregnancy using a pediatric-based protocol incorporating pegylated asparaginase.
Jeffrey A; Presgrave P; Walsh CA; Sinn J; Kennedy D; Anazodo A; Kumar P; Osborn M; Trahair T; Bradstock K; Dalla-Pozza L; Greenwood M
Leuk Lymphoma; 2023; 64(11):1880-1883. PubMed ID: 37516923
[No Abstract] [Full Text] [Related]
13. A new onset drug induced diabetes mellitus presenting with diabetic ketoacidosis in a child undergoing treatment for B cell acute lymphoblastic leukemia. A case report and review of literature.
Sharma P; Vyas V; Didel S; Singh K
J Pediatr Endocrinol Metab; 2024 Apr; 37(4):367-370. PubMed ID: 38281148
[TBL] [Abstract][Full Text] [Related]
14. Thrombin Generation Assay Proved the Increasing Thrombin Production After Native Escherichia coli Asparaginase in Pediatric Acute Lymphoblastic Leukemia According to ThaiPOG2021 Protocol.
Torchareon T; Chaweephisal P; Akkawat B; Sosothikul D
J Pediatr Hematol Oncol; 2023 Nov; 45(8):e1035-e1037. PubMed ID: 37801571
[No Abstract] [Full Text] [Related]
15. Increasing completion of asparaginase treatment in childhood acute lymphoblastic leukaemia (ALL): summary of an expert panel discussion.
Baruchel A; Brown P; Rizzari C; Silverman L; van der Sluis I; Wolthers BO; Schmiegelow K
ESMO Open; 2020 Sep; 5(5):e000977. PubMed ID: 32967920
[TBL] [Abstract][Full Text] [Related]
16. Treatment and outcomes of symptomatic hyperammonemia following asparaginase therapy in children with acute lymphoblastic leukemia.
Lee A; Eldem I; Altintas B; Nguyen H; Willis D; Langley R; Shinawi M
Mol Genet Metab; 2023 Jul; 139(3):107627. PubMed ID: 37327713
[TBL] [Abstract][Full Text] [Related]
17. Thrombotic potential during pediatric acute lymphoblastic leukemia induction: Role of cell-free DNA.
Kumar R; Katare PB; Lentz SR; Modi AJ; Sharathkumar AA; Dayal S
Res Pract Thromb Haemost; 2021 Jul; 5(5):e12557. PubMed ID: 34337307
[TBL] [Abstract][Full Text] [Related]
18. Correlation of ex vivo and in vivo ammonia production with L-asparaginase biological activity in adults with lymphoid malignancies.
Nakamura T; Oya S; Ozawa H; Maehiro Y; Muta S; Umeda M; Takaki Y; Fukuyama T; Yamasaki Y; Yamaguchi M; Aoyama K; Mouri F; Naito Y; Nagafuji K
Int J Hematol; 2024 Apr; 119(4):426-431. PubMed ID: 38363480
[TBL] [Abstract][Full Text] [Related]
19. Superior sagittal sinus thrombosis in the course of mixed phenotype acute leukaemia treated with acute lymphoblastic leukaemia-like therapy-a case report.
Lizurej W; Mazurkiewicz Ł; Kowalski M; Szydłowska S; Wyrzykowski M; Lewandowski K
Thromb J; 2023 Nov; 21(1):117. PubMed ID: 37974201
[TBL] [Abstract][Full Text] [Related]
20. Anticoagulant effects of protein C, protein S, and antithrombin levels on the protein C pathway in young children.
Nakagawa T; Ogiwara K; Tonegawa H; Takahashi Y; Nishikubo T; Nogami K
Int J Hematol; 2024 Feb; 119(2):196-204. PubMed ID: 38228939
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
